Studies on uptake, sub-cellular trafficking and efflux of antisense oligodeoxynucleotides in glioma cells using self-assembling cationic Lipoplexes as delivery systems

Journal of Drug Targeting

Volumn 7, Issue 5, 1999, Pages 373-382

  Islam, Aminul ^a   Handley, Sheila L ^a   Thompson, Kevin S J ^b   Akhtar, Saghir ^a  

^a ASTON UNIVERSITY   (United Kingdom)

^b ABBOTT LABORATORIES   (United States)

Author keywords

Antisense oligonucleotides; C6 glioma cells; Cationic liposomes; Cellular uptake and distribution; Drug delivery

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; DRUG CARRIER; LIPOSOME;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; CELL ULTRASTRUCTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DRUG DISTRIBUTION; DRUG UPTAKE; ENDOSOME; GLIOMA CELL; INTRACELLULAR TRANSPORT; ISOTOPE LABELING; LYSOSOME; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSMISSION ELECTRON MICROSCOPY;

EID: 0034057326     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/10611869909085520     Document Type: Article

References (25)

1. Akhtar, S. (1998). Antisense technology: Selection and delivery of optimally acting antisense oligonucleotides. J. Drug Targeting, 5: 225-234.
2. Akhtar, S. and Agrawal, S. (1997). In vivo studies with antisense oligonucleotide. Trends Pharmacol. Sci., 18: 12-18.
3. Akhtar, S. and Juliano, R.L. (1992). Cellular uptake and intracellular fate of antisense oligonucleotides. Trends Cell. Biol., 2: 139-144.
4. Akhtar, S., Kole, R. and Juliano, R.L. (1991). Stability of antisense DNA oligodeoxynucleotide analogs in cellular extracts and sera. Life Sci., 49: 1793-1801.
5. Armbruster, B.L., Carlemalm, E., Chiovetti, R., Garavito, R.M., Hobot, J.A., Kellenberger, E. and Villiger, W. (1982). Specimen preparations for electron-microscopy using low-temperature embedding resins. J. Microscopy-Oxford, 126: 77-85.
6. Beltinger, C., Saragovi, H.U., Smith, R.M., Lesauteur, L., Shah, N., Dedionisio, L., Christensen, L., Raible, A., Jarett, L. and Gewirtz, A.M. (1995). Binding, uptake, and intracellular trafficking of phosphorothioate modified oligodeoxynucleotides. J. Clin. Invest., 95: 1814-1823.
7. Bennett, C.F., Chiang, M.Y., Chan, H., Shoemaker, J.E.E. and Mirabelli, C.K. (1992). Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol. Pharmacol., 41: 1023-1033.
8. Chin, D.J., Green, G.A., Zon, G., Szoka Jr., F.C. and Straubinger, R.M. (1990). Rapid nuclear accumulation of injected oligodeoxyribonucleotides. New Biol., 2: 1091-1100.
9. Farhood, H., Bottega, R., Epand, R.M. and Huang, L. (1992). Effect of cationic cholesterol derivatives on gene transfer and protein kinase C activity. Biochim. Biophys. Acta, 1111: 239-246.
10. Fell, P.L., Hudson, A.J., Reynolds, M.A. and Akhtar, S. (1997). Cellular uptake properties of a 2′-amino/2′-o-methyl-modified chimeric hammerhead ribozyme targeted to the epidermal growth factor receptor mRNA. Antisense Nucleic Acid Drug Develop., 7: 319-326.
11. Guy-Caffey, J.K., Bodepudi, V., Bishop, J.S., Jayaraman, K. and Chaudhary, N. (1995). Novel polyaminolipids enhance the cellular uptake of oligonucleotides. J. Biol. Chem., 270: 31 391-31 396.
12. Juliano, R.L., Alahari, S., Yoo, H., Kole, R. and Cho, M. (1999). Antisense pharmacodynamics: Critical issues in the transport and delivery of antisense oligonucleotides. Pharm. Res. 16: 494-502.
13. Loke, S.L., Stein, C., Zhang, X.H., Mori, K., Nakanishi, M., Subasinghe, C., Cohen, J.S. and Neckers, L.M. (1989). Characterisation of oligonucleotide transport into living cells. Proc. Natl. Acad. Sci. USA, 86: 3474-3478.
14. Nellen, W. and Sczakiel, G. (1996). In vitro and in vivo action of antisense RNA. Mol. Biotech., 6: 7-15.
15. Puyal, C., Millhaud, P., Bienvenue, A. and Philippot, J.R. (1995). A new cationic liposome encapsulating genetic material. A potential delivery system for polynucleotides. Eur. J. Biochem., 228: 697-703.
16. Quattrone, A., Papucci, L., Schiavone, N., Mini, E. and Capaccioli, S. (1994). Intracellular enhancement of intact antisense oligonucleotide steady-state levels by cationic lipids. Anti-Cancer Drug Design, 9: 574-579.
17. Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual. Second Edition. Cold Spring Harbor Laboratory Press. NY, pp. 11.20-11.28.
18. Shoji, Y., Akhtar, S., Periasamy, A., Herman, B. and Juliano, R.L. (1991). Mechanisms of cellular uptake of modified oligodeoxynucleotides containing methylphosphonate linkages. Nucleic Acids Res., 19: 5543-5550.
19. Stegmann, T. and Legendre, J.-Y. (1997). Gene transfer mediated by cationic lipids: lack of correlation between lipid mixing and transfection. Biochim. Biophys. Acta, 1325: 71-79.
20. Tarrason, G., Bellido, D., Eritja, R., Vilaro, S. and Piulats, J. (1995). Digoxigenin-labelled phosphorothioate oligonucleotides. A new tool for the study of cellular uptake. Antisense Res. Dev., 5: 193-201.
21. Tonkinson, J.L. and Stein, C.A. (1994). Patterns of intracellular compartmentalization, trafficking and acidification of 5′-fluorescein labelled phosphodiester and phosphorothioate oligodeoxynucleotides in HL-60 cells. Nucleic Acids Res., 22: 4268-4275.
22. Wagner, R.W. (1994). Gene inhibition using antisense oligodeoxynucleotides. Nature, 312: 333-335.
23. Zabner, J. (1997). Cationic lipids used in gene transfer. Advanced Drug Delivery Rev., 27: 17-28.
24. Zelphati, O. and Szoka Jr., F.C. (1996). Intracellular distribution and mechanism of delivery of oligonucleotides mediated by cationic lipids. Pharm. Res., 13: 1367-1372.
25. Zhou, X. and Huang, L. (1994). DNA transfection mediated by cationic liposomes containing lipopolylysine: Characterization and mechanism of action. Biochim. Biophys. Acta, 1189: 195-203.